Breast cancer survival in Ethiopia: A cohort study of 1,070 women

International Journal of Cancer

Volumn 135, Issue 3, 2014, Pages 702-709

  Kantelhardt, E J ^a   Zerche, P ^a   Mathewos, A ^b   Trocchi, P ^a   Addissie, A ^b   Aynalem, A ^b   Wondemagegnehu, T ^b   Ersumo, T ^b   Reeler, A ^c   Yonas, B ^b   Tinsae, M ^b   Gemechu, T ^b   Jemal, A ^d,e   Thomssen, C ^a   Stang, A ^b   Bogale, S ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c Axios International   (France)

^d AMERICAN CANCER SOCIETY   (United States)

^e BOSTON UNIVERSITY   (United States)

Author keywords

Africa; Breast neoplasms; Ethiopia; Prognosis; Survival

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS FREE SURVIVAL; ETHIOPIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; VERY ELDERLY; YOUNG ADULT;

AFRICA; BREAST NEOPLASMS; ETHIOPIA; PROGNOSIS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; COMBINED MODALITY THERAPY; ETHIOPIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84901053010     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28691     Document Type: Article

References (39)

1. http://esa.un.org/unpd/wpp/Excel-Data/population.htm.
2. Central Statistical Agency [Ethiopia] and ICF International. 2012. Ethiopia Demographic and Health Survey 2011; 2012.
3. Policy Planning Directorate. Health and Health Related Indicators 2010/2011; 2012.
4. www.afro.who.int.
5. Jemal A, Bray F, Forman D, et al. Cancer burden in Africa and opportunities for prevention. Cancer 2012; 118: 4372-84.
6. McCormack VA, Boffetta P,. Today's lifestyles, tomorrow's cancers: trends in lifestyle risk factors for cancer in low-and middle-income countries. Ann Oncol 2011; 22: 2349-57.
7. Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents, vol. 9. IARC Scientific Publications No. 160. Lyon, France: International Agency for Research on Cancer, 2007.
8. Kantelhardt EJ, Hanson C, Albert US, et al. Breast cancer in countries of limited resources. Breast Care 2008; 3: 127.
9. http://globocan.iarc.fr.
10. http://www.who.int/cancer/media/news/WHA58%2022-en.pdf.
11. Love RR,. Defining a global research agenda for breast cancer. Cancer 2008; 113: 2366-71.
12. Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011; 12: 387-98.
13. Anderson BO, Shyyan R, Eniu A, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J 2006; 12 (Suppl 1): S3-S15.
14. Reeler AV, Sikora K, Solomon B,. Overcoming challenges of cancer treatment programmes in developing countries: a sustainable breast cancer initiative in Ethiopia. Clin Oncol (R Coll Radiol) 2008; 20: 191-8.
15. Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon, France: WHO, 1991.
16. Edge SB,. AJCC cancer staging manual, 7th edn. New York: Springer, 2010.
17. Sobin L, Gospodarowicz M, Wittekind C, eds. TNM classification of malignant tumors, 7th edn. Hoboken, NJ: Wiley, 2009.
18. Greenland S, Pearl J, Robins JM,. Causal diagrams for epidemiologic research. Epidemiology 1999; 10: 37-48.
19. Knuppel S, Stang A,. DAG program: identifying minimal sufficient adjustment sets. Epidemiology 2010; 21: 159.
20. Schoenfeld D,. Partial residuals for the proportional hazards regression model. Biometrika 1982; 69: 238-41.
21. Agboola AJ, Musa AA, Wanangwa N, et al. Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women. Breast Cancer Res Treat 2012; 135: 555-69.
22. Youlden DR, Cramb SM, Dunn NAM, et al. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol 2012; 36: 237-48.
23. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010; 11: 165-73.
24. Gakwaya A, Kigula-Mugambe JB, Kavuma A, et al. Cancer of the breast: 5-year survival in a tertiary hospital in Uganda. Br J Cancer 2008; 99: 63-7.
25. Ersumo T,. Breast cancer in an Ethiopian population, Addis Ababa. East Central Afr J Surg 2006; 11: 81-6.
26. Ly M, Antoine M, Dembele AK, et al. High incidence of triple-negative tumors in sub-Saharan Africa: a prospective study of breast cancer characteristics and risk factors in Malian women seen in a Bamako University Hospital. Oncology 2012; 83: 257-63.
27. Rambau PF, Chalya PL, Manyama MM, et al. Pathological features of breast cancer seen in Northwestern Tanzania: a nine years retrospective study. BMC Res Notes 2011; 4: 214.
28. Ohene-Yeboah M, Adjei E,. Breast cancer in Kumasi, Ghana. Ghana Med J 2012; 46: 8-13.
29. Adebamowo CA, Famooto A, Ogundiran TO, et al. Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 2008; 110: 183-8.
30. Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62: 220-41.
31. Mbonde MP, Amir H, Akslen LA, et al. Expression of oestrogen and progesterone receptors, Ki67, p53 and BCL-2 proteins, cathepsin D, urokinase plasminogen activator and urokinase plasminogen activator-receptors in carcinomas of the female breast in an African Population. East Afr Med J 2001; 78: 360-5.
32. Mousa SM, Seifeldin IA, Hablas A, et al. Patterns of seeking medical care among Egyptian breast cancer patients: relationship to late-stage presentation. Breast 2011; 20: 555-61.
33. Huo D, Ikpatt F, Khramtsov A, et al. Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancer. J Clin Oncol 2009; 27: 4515-21.
34. Thorat MA, Rangole A, Nadkarni MS, et al. Revision surgery for breast cancer: single-institution experience. Cancer 2008; 113: 2347-52.
35. Maskarinec G, Sen C, Koga K, et al. Ethnic differences in breast cancer survival: status and determinants. Womens Health (Lond Engl) 2011; 7: 677-87.
36. Jakobsson M, Scholz SW, Scheet P, et al. Genotype, haplotype and copy-number variation in worldwide human populations. Nature 2008; 451: 998-1003.
37. Akarolo-Anthony SN, Ogundiran TO, Adebamowo CA,. Emerging breast cancer epidemic: evidence from Africa. Breast Cancer Res 2010; 12 (Suppl 4): S8.
38. Dye TD, Bogale S, Hobden C, et al. Complex care systems in developing countries: breast cancer patient navigation in Ethiopia. Cancer 2010; 116: 577-85.
39. Sankaranarayanan R, Sauvaget C, Ramadas K, et al. Clinical trials of cancer screening in the developing world and their impact on cancer healthcare. Ann Oncol 2011; 22 (Suppl 7): vii20-vii28.